Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01013935 · ClinicalTrials.gov registry record · NA
A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 556
- Enrollment target
NCT01013935: Completed NA study, sponsored by New York University.
NCT01013935 is a NA study that has completed, run by New York University. The registered enrollment target is 556 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01013935, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 556 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a computer counseling tool helps Spanish-speaking people living with HIV to have safer sex and to do well on their HIV medicines.
Interventions
- OTHER CARE+ Spanish computer counseling session
- OTHER CARE+ Spanish brief computer risk assessment session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 556 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01013935 record still lists
NCT01013935 is an interventional study that assigns participants to a tested intervention. The registered 556 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which CARE+ Spanish computer counseling session is the first listed.
NCT01013935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01013935 about?
NCT01013935 is a clinical study titled "A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]". The purpose of this study is to see if a computer counseling tool helps Spanish-speaking people living with HIV to have safer sex and to do well on their HIV medicines.
What is the current status of trial NCT01013935?
This trial is currently completed. It is a NA study. The enrollment target is 556 participants. The study started on 2010-06. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01013935?
The interventions under investigation include: CARE+ Spanish computer counseling session (OTHER), CARE+ Spanish brief computer risk assessment session (OTHER).
Who is sponsoring clinical trial NCT01013935?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01013935's enrollment target sits among peer trials
556 184th of 2000 higher than 1,817 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT06799000 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia